2022
DOI: 10.1245/s10434-022-12464-6
|View full text |Cite
|
Sign up to set email alerts
|

Sustained Systemic Inflammatory Response Predicts Survival in Patients with Hepatocellular Carcinoma After Hepatic Resection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 29 publications
0
12
0
Order By: Relevance
“…Regarding preoperative NLR, non‐solving inflammatory response, which cannot be improved by surgical resection, may persist and substantially lead to cancer development and metastasis during perioperative period. A previous study reported sustained systemic inflammatory response with associated with poor oncological outcomes 7 . As a cause of postoperative inflammation, the pulmonary complication was also a risk factor.…”
Section: Discussionmentioning
confidence: 92%
See 3 more Smart Citations
“…Regarding preoperative NLR, non‐solving inflammatory response, which cannot be improved by surgical resection, may persist and substantially lead to cancer development and metastasis during perioperative period. A previous study reported sustained systemic inflammatory response with associated with poor oncological outcomes 7 . As a cause of postoperative inflammation, the pulmonary complication was also a risk factor.…”
Section: Discussionmentioning
confidence: 92%
“…Biomarkers represent the systemic inflammation in various malignancies; CAR, LMR, NLR, PLR, and Glasgow prognostic scores were determined as prognostic factors. 7,[11][12][13][14] Regarding esophagectomy for EC, preoperative systemic inflammation markers were reported to be of prognostic value. 4 However, the number of research regarding this is limited.…”
Section: Risk Factors For the Systemic Inflammation-highmentioning
confidence: 99%
See 2 more Smart Citations
“…4 ALBI grade has more sensitively stratified outcomes of HCC patients. 5 A growing body of evidence suggests that the systemic inflammatory response including neutrophillymphocyte ratio (NLR), 6 platelet-lymphocyte ratio (PLR), 7 lymphocyte-monocyte ratio (LMR), 8 C-reactive protein-albumin ratio (CAR) 9 has been associated with long-term outcomes in cancer patients including HCC.…”
Section: Introductionmentioning
confidence: 99%